Results 21 to 30 of about 296,723 (312)

Study of Serum Leptin in Well-differentiated Thyroid Carcinoma: Correlation with Patient and Tumor Characteristics [PDF]

open access: yes, 2014
Background There is a proven relationship between obesity and several cancers including breast, endometrium, colorectal, and esophagus. With the increasing incidence of both obesity and thyroid cancer, we designed the present study to investigate a ...
Abdel-Aziz, TE   +3 more
core   +1 more source

Frequency and significance of Ras, Tert promoter, and Braf mutations in cytologically indeterminate thyroid nodules: A monocentric case series at a tertiary-level Endocrinology unit [PDF]

open access: yes, 2017
PurposeThe management of thyroid nodules of indeterminate cytology is controversial. Our study aimed to establish the frequency and significance of H-,K-,N-RAS, TERT promoter, and BRAF gene mutations in thyroid nodes of indeterminate cytology and to ...
Barollo, Susi   +13 more
core   +2 more sources

Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer

open access: yesScientific Reports, 2023
Papillary carcinomas account for the largest proportion of thyroid cancers, with papillary thyroid carcinoma (PTC) being prone to early lymph node metastasis.
Ben Zhang   +7 more
doaj   +1 more source

Non recurrent laryngeal nerve with right aberrant subclavian artery in recurrent case of papillary carcinoma of thyroid: an interesting clinical entity. [PDF]

open access: yes, 2013
Background/objectives: A nonrecurrent laryngeal nerve is a rare anatomical variant and a routine preoperative imaging studies are not indicated. NRLN is related with absence of the brachiocephalic trunk and aberrant (mainly retroesophageal) course of ...
Chavan, Purshottam   +5 more
core   +2 more sources

Recent advances in managing differentiated thyroid cancer [PDF]

open access: yes, 2018
The main clinical challenge in the management of thyroid cancer is to avoid over-treatment and over-diagnosis in patients with lower-risk disease while promptly identifying those patients with more advanced or high-risk disease requiring aggressive ...
Durante, Cosimo   +3 more
core   +2 more sources

Hürthle cell carcinoma: current perspectives. [PDF]

open access: yes, 2016
Hürthle cell carcinoma (HCC) can present either as a minimally invasive or as a widely invasive tumor. HCC generally has a more aggressive clinical behavior compared with the other differentiated thyroid cancers, and it is associated with a higher rate ...
Ahmadi, Sara   +3 more
core   +1 more source

Unmodifiable variables related to thyroid cancer incidence [PDF]

open access: yes, 2018
The incidence of thyroid cancer is significantly different between male and female patients. Thyroid cancer is also the only form of cancer where age can be considered a staging variable.
Alecu, Lucian   +10 more
core   +2 more sources

Tyrosine kinase inhibitors for the therapy of anaplastic thyroid cancer [PDF]

open access: yes, 2015
Anaplastic thyroid cancer (ATC) is often incurable so new therapeutic approaches are needed. Tyrosine kinases inhibitors (such as imanitib, sunitinib or sorafenib) are under evaluation for the treatment of ATC.
Bond JA   +11 more
core   +1 more source

FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner

open access: yesJournal of Experimental & Clinical Cancer Research, 2022
Background N6-methyladenosine (m6A) modification is the most common chemical modification in mammalian mRNAs, and it plays important roles by regulating several cellular processes.
Jiapeng Huang   +11 more
doaj   +1 more source

Public perceptions of changing the terminology for low-risk thyroid cancer: A qualitative focus group study [PDF]

open access: yes, 2019
Objectives To investigate public perceptions of overdiagnosis and overtreatment in low-risk thyroid cancer and explore opinions regarding the proposed strategy to change the terminology of low-risk cancers.
Barratt, Alexandra   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy